Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP607443.RAJ-xmISmeYnLlnmfZacPhVMWm8JyzD0xV--bFQw-tejg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP607443.RAJ-xmISmeYnLlnmfZacPhVMWm8JyzD0xV--bFQw-tejg130_assertion type Assertion NP607443.RAJ-xmISmeYnLlnmfZacPhVMWm8JyzD0xV--bFQw-tejg130_head.
- NP607443.RAJ-xmISmeYnLlnmfZacPhVMWm8JyzD0xV--bFQw-tejg130_assertion description "[The neoplastic EC cell is characterized by loss of TGFbeta-1-mediated growth inhibition and, similar to glioblastomas, utilizes the TGFbeta system to induce gene responses associated with growth promotion (c-Myc and the ERK pathway), invasion (E-cadherin), and metastasis (MTA1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607443.RAJ-xmISmeYnLlnmfZacPhVMWm8JyzD0xV--bFQw-tejg130_provenance.
- NP607443.RAJ-xmISmeYnLlnmfZacPhVMWm8JyzD0xV--bFQw-tejg130_assertion evidence source_evidence_literature NP607443.RAJ-xmISmeYnLlnmfZacPhVMWm8JyzD0xV--bFQw-tejg130_provenance.
- NP607443.RAJ-xmISmeYnLlnmfZacPhVMWm8JyzD0xV--bFQw-tejg130_assertion SIO_000772 17469181 NP607443.RAJ-xmISmeYnLlnmfZacPhVMWm8JyzD0xV--bFQw-tejg130_provenance.
- NP607443.RAJ-xmISmeYnLlnmfZacPhVMWm8JyzD0xV--bFQw-tejg130_assertion wasDerivedFrom befree-2016 NP607443.RAJ-xmISmeYnLlnmfZacPhVMWm8JyzD0xV--bFQw-tejg130_provenance.
- NP607443.RAJ-xmISmeYnLlnmfZacPhVMWm8JyzD0xV--bFQw-tejg130_assertion wasGeneratedBy ECO_0000203 NP607443.RAJ-xmISmeYnLlnmfZacPhVMWm8JyzD0xV--bFQw-tejg130_provenance.